Skip to main content
Book Chapter

Neuroprotection in Amyotrophic Lateral Sclerosis

  • Jain K
Humana Press, (2011), 385-408
DOI: 10.1007/978-1-61779-049-2_10
N/ACitations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

… Only two drugs, riluzole and edaravone, are approved by the FDA for the treatment of ALS. Riluzole suppresses excessive motor neuron firing and edaravone suppressing oxidative stress; both provide a limited improvement in survival. Table 10.3 … Edaravone for ALS …

Cite

CITATION STYLE

APA

Jain, K. K. (2011). Neuroprotection in Amyotrophic Lateral Sclerosis. In The Handbook of Neuroprotection (pp. 385–408). Humana Press. https://doi.org/10.1007/978-1-61779-049-2_10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free